Chloroquine, an antimalarial medicine that has been on the international market since 1934, proves to be active against the novel SARS coronavirus type 2 (COVID-19). The antiviral activity of chloroquine was already discovered in 2004 by a team of virologists at KU Leuven.
Experts from the Chinese Ministry of Science and Technology confirmed at a press conference on 17 February that chloroquine has a curative effect in clinical trials on patients with COVID-19. The trials were conducted in patients in 10 hospitals in Beijing, Hunan, and Guangdong. ...